Trial intelligence / Profile preview

COMBIGaPP: 5-FU PK-guided Dosing in DPD Deficiency

NCT06782022Phase 2Completed

Start
Feb 2020
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of fluorouracil in gastrointestinal cancer. Started Feb 2020; status: completed.

02

Drugs

fluorouracil
03

Conditions

gastrointestinal cancer

Beyond the preview

Go deeper on NCT06782022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06782022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call